GlassScriptPhysician profile
Albert Craig Pearce
NPI 1598737835
$12,211.58
in general payments reported to CMS, 2019-2025
37 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,774 · 2020: $1,633 · 2021: $3,667 · 2022: $656 · 2023: $582 · 2024: $130 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606 · Travel and Lodging: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.48 |
| Travel and Lodging | $874.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,496.85 | 2019-2023 | Impella |
| Medtronic, INC. | $1,690.21 | 2021-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,148.89 | 2019-2020 | |
| Penumbra, INC. | $1,022.84 | 2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $602.22 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $542.51 | 2019-2024 | Uptravi |
| Shockwave Medical, INC | $467.56 | 2025 | |
| Pfizer INC. | $444.72 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $411.82 | 2019-2021 | |
| Biotronik INC. | $371.57 | 2021-2022 | |
| Abbott Laboratories | $345.01 | 2019-2025 | Diamondback Peripheral, Diamondback Coronary |
| Sanofi-Aventis U.S. LLC | $335.38 | 2019-2021 | |
| Boston Scientific Corporation | $293.43 | 2019-2025 | General - Vascular Intervention |
| Novartis Pharmaceuticals Corporation | $292.33 | 2019-2023 | |
| Amgen INC. | $242.72 | 2019-2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Pearce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.